Format

Send to

Choose Destination
See comment in PubMed Commons below
J Vasc Surg. 2014 Sep;60(3):686-95.e2. doi: 10.1016/j.jvs.2014.03.290. Epub 2014 May 10.

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population.

Author information

1
Vascular Surgery Section, Department of Surgery, University of Colorado Denver, Aurora, Colo. Electronic address: mark.nehler@ucdenver.edu.
2
Lillehei Clinical Research Unit, Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minn.
3
Department of Medicine, CPC Clinical Research, Aurora, Colo.
4
Division of Cardiovascular Medicine, Department of Medicine, University of Virginia, Charlottesville, Va.
5
Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, and Department of Medicine, CPC Clinical Research, Aurora, Colo.
6
Lockheed Martin, Aurora, Colo.
7
Vascular Medicine Program, Lillehei Heart Institute and Cardiovascular Division, University of Minnesota Medical School, Minneapolis, Minn.

Abstract

BACKGROUND:

Critical limb ischemia (CLI) represents the most severe clinical manifestation of peripheral arterial disease (PAD) and is the major cause of ischemic amputation in the United States. Risk factors and the associated incidence and prevalence of CLI have not been well described in the general population. This study describes the risk factors for PAD progression to CLI and estimates the annual incidence and prevalence of CLI in a representative United States patient cohort.

METHODS:

This was a retrospective cohort analysis of adults with commercial, Medicare supplemental, or Medicaid health insurance who had at least one PAD or CLI health care claim from January 1, 2003, through December 31, 2008, and 12 months of continuous coverage. Two subgroups of CLI presentation were identified: primary CLI (patients without any prior PAD or subsequent PAD diagnostic code >30 days after CLI diagnostic code) and secondary CLI (patients with prior PAD or subsequent PAD diagnostic codes ≤30 days of a CLI diagnostic code). Patterns of presentation, annual incidence, and prevalence of CLI were stratified by health care plan. Risk factors for progression to CLI were compared by presentation type.

RESULTS:

From 2003 to 2008, the mean annual incidence of PAD was 2.35% (95% confidence interval [CI], 2.34%-2.36%) and the incidence of CLI was 0.35% (95% CI, 0.34%-0.35%) of the eligible study population, with primary and secondary presentations occurring at similar rates. The mean annualized prevalence of PAD was 10.69% (95% CI, 10.67%10.70%) and the mean annualized prevalence of CLI was 1.33% (95% CI, 1.32%-1.34%) of the eligible study population, and two-thirds of the cases presented as secondary CLI. CLI developed in 11.08% (95% CI, 11.30%-11.13%) of patients with PAD. A multivariable model demonstrated that diabetes, heart failure, stroke, and renal failure were stronger predictors of primary rather than secondary CLI presentation.

CONCLUSIONS:

These data establish new national estimates of the incidence and prevalence of CLI and define key risk factors that contribute to primary or secondary presentations of CLI within a very large contemporary insured population cohort in the United States.

PMID:
24820900
DOI:
10.1016/j.jvs.2014.03.290
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center